Who We Are

Mid Atlantic
Bio Angels Group

Mid Atlantic Bio Angels group (MABA), is an angel investor group focused exclusively on new and emerging life science companies. Membership in MABA is by invitation only, and is extended to active, accredited investors (life science angels) who wish to make investments in life science companies, as well as institutional investors and life science company venture arms wishing to invest alongside the angels.

MABA places no geographical restrictions or requirements for presenting companies, as long as meaningful and effective post-investment monitoring of these companies can be achieved.

MABA angels meet monthly (except in the summer) in the New York City area, to hear presentations from companies spanning the entire spectrum of life sciences.

Our group follows a multi-step pre-screening process, prior to inviting companies to present to our group. Please visit the "Entrepreneurs" tab to read our investment criteria and to submit an application to our group.

If you are an active life science angel investor, and wish to join our group, please visit our Members page.


MABA maintains an active dialogue with and seeks to invest and share due diligence with other angels and angel groups.

In June of 2016 MABA formed a closed-end investment pool (Pool) funded solely by current, active MABA members.  The Pool is intended to enable these members to diversify their portfolios by collectively making more frequent, and smaller investments in a greater number of companies (Pool press release).

MABA also organizes a series of events called 1st Pitch Life Science to encourage and educate aspiring life science entrepreneurs who know they may be too early to seek investment but want the opportunity to practice their pitch and to receive constructive criticism from experienced and knowledgeable professionals.

* * * * *

Join Us

Upcoming Meetings

February 15th, 2022 Confirm attendance
March 15th, 2022 Confirm attendance
April 26th, 2022 Confirm attendance
May 24th, 2022 Confirm attendance
June 21st, 2022 Confirm attendance
Deals We Have Invested In

Cerus Endovascular (Cerus Endovascular website )

Immunomic Therapeutics, Inc. (Immunomic Therapeutics website )

Opsidio, LLC (Opsidio website)

Evrys Bio (previously FORGE Life Sciences) (Evrys Bio website) (Press release)

Genome Profiling LLC (GenPro) (GenPro website) (Press release)

PainQx (PainQx website) (Press Release)

New View Surgical (New View Surgical website) (Press Release)

Elysium Therapeutics (Press Release

FEMSelect (previously POP Medical Solutions) (FEMSelect website) (Press Release)

Thermalin, Inc (Thermalin website)

Virion Therapeutics (Virion website)

Sana Health (Sana Health Website)

Healionics (Healionics Website) (Press Release)

Astrocyte Pharmaceuticals (Astrocyte Pharmaceuticals Website)

Seneca Therapetics (Seneca Therapeutics Website)

Supporting Sponsors
Eisner Amper Accountants & Advisors                  JQA Partners - Strategic Communications      Wilson Sonsini Goodrich & Rosati Professional Corporation Courage Growth Partners RBW Consulting kmac connect
Founding Sponsors